Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Structure Function Studies of the Role of DNAJA2 in Alzheimer's Disease
FY 2021-22
Summary
Over 500,000 Canadians currently have dementia, the most common of which is Alzheimers Disease. In Alzheimers, the tau protein misfolds and forms larger toxic aggregates/clumps in the brain. Tau aggregate accumulation is associated with disease pathology. Chaperones are proteins which normally protect against protein misfolding by unfolding them and allowing them to adopt their proper confirmation. DNAJA2 is a chaperone which has been found to be expressed at higher levels in Alzheimers patients brain samples and has also been shown to inhibit the formation of tau aggregates in a test tube. Consequently, DNAJA2's increased expression may be part of the bodys attempt to manage increased protein misfolding and aggregation in Alzheimers disease.
The purpose of our research is to determine the molecular mechanism by which DNAJA2 can prevent tau aggregation. An antibody which binds a variety of protein aggregates associated with neurodegenerative diseases was also found to bind DNAJA2. DNAJA2s ability to inhibit tau aggregation may be due to a common structural feature (epitope) found on both itself and tau aggregates. In order to determine this specific feature, we will sequentially mutate each of DNAJA2s amino acids. With this collection of mutants, we can then assess the effects of each mutation on the reactivity to the antibody as well DNAJA2s ability to inhibit tau aggregation. We can then see if there is a correlation between these results to determine the shared epitope. This research is beneficial as it may allow this structural feature to be mimicked to provide a preventative measure against neurodegenerative diseases and contribute to the collective understanding of neurodegenerative diseases develop.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
467113
Name
Sun Kerry
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Structure Function Studies of the Role of DNAJA2 in Alzheimer's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; High-Throughput; Mutational Scanning; Protein Aggregation; Protein Chaperones; Protein Purification; Tauopathies
Abstract
Over 500,000 Canadians currently have dementia, the most common of which is Alzheimers Disease. In Alzheimers, the tau protein misfolds and forms larger toxic aggregates/clumps in the brain. Tau aggregate accumulation is associated with disease pathology. Chaperones are proteins which normally protect against protein misfolding by unfolding them and allowing them to adopt their proper confirmation. DNAJA2 is a chaperone which has been found to be expressed at higher levels in Alzheimers patients brain samples and has also been shown to inhibit the formation of tau aggregates in a test tube. Consequently, DNAJA2's increased expression may be part of the bodys attempt to manage increased protein misfolding and aggregation in Alzheimers disease.
The purpose of our research is to determine the molecular mechanism by which DNAJA2 can prevent tau aggregation. An antibody which binds a variety of protein aggregates associated with neurodegenerative diseases was also found to bind DNAJA2. DNAJA2s ability to inhibit tau aggregation may be due to a common structural feature (epitope) found on both itself and tau aggregates. In order to determine this specific feature, we will sequentially mutate each of DNAJA2s amino acids. With this collection of mutants, we can then assess the effects of each mutation on the reactivity to the antibody as well DNAJA2s ability to inhibit tau aggregation. We can then see if there is a correlation between these results to determine the shared epitope. This research is beneficial as it may allow this structural feature to be mimicked to provide a preventative measure against neurodegenerative diseases and contribute to the collective understanding of neurodegenerative diseases develop.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sun, Kerry
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~